Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Taskeen Iqbal Janjua"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 9, p 2239 (2023)
The presence of the blood–brain barrier (BBB) limits the delivery of therapies into the brain. There has been significant interest in overcoming the BBB for the effective delivery of therapies to the brain. Inorganic nanomaterials, especially silic
Externí odkaz:
https://doaj.org/article/7c4d34682d5541669347bf2f736f9955
Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma
Autor:
Taskeen Iqbal Janjua, Yuxue Cao, Aria Ahmed-Cox, Aun Raza, Md Moniruzzaman, Dewan Taslima Akhter, Nicholas L. Fletcher, Maria Kavallaris, Kristofer J. Thurecht, Amirali Popat
Publikováno v:
Journal of Controlled Release. 357:161-174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::869d9a994271434fb0f56f31c35614fe
https://doi.org/10.1016/j.jconrel.2023.03.040
https://doi.org/10.1016/j.jconrel.2023.03.040
Autor:
Aun Raza, Gustavo Rodrigues Rossi, Taskeen Iqbal Janjua, Fernando Souza-Fonseca-Guimaraes, Amirali Popat
Publikováno v:
Trends in Biotechnology. 41:77-92
Natural killer (NK) cells have emerged as a major target for cancer immunotherapies, particularly as cellular therapy modalities because they have relatively less toxicity than T lymphocytes. However, NK cell-based therapy suffers from many challenge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f4669e73d7774c30f8e40c6b89b464
https://doi.org/10.1016/j.tibtech.2022.06.011
https://doi.org/10.1016/j.tibtech.2022.06.011
Autor:
Anand Kumar Meka, Akshatha Gopalakrishna, Claudia Iriarte-Mesa, Prarthana Rewatkar, Zhi Qu, Xiaoxin Wu, Yuxue Cao, Indira Prasadam, Taskeen Iqbal Janjua, Freddy Kleitz, Tushar Kumeria, Amirali Popat
Publikováno v:
Molecular Pharmaceutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ff84491877c4adbb9654dfe5c9ca4f9
https://doi.org/10.1021/acs.molpharmaceut.3c00017
https://doi.org/10.1021/acs.molpharmaceut.3c00017
Autor:
Yuxue Cao, Taskeen Iqbal Janjua, Zhi Qu, Bastian Draphoen, Yunfan Bai, Mika Linden, Md. Moniruzzaman, Sumaira Hasnain, Tushar Kumeria, Amirali Popat
Publikováno v:
Biomaterials Science.
Nanoparticle based permeation enhancers have the potential to improve oral delivery of biologics. Recently, solid silica nanoparticles were discovered to improve intestinal permeability of peptides and proteins via transient opening...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af4e4f1595562568e6b900e9d2654ced
https://doi.org/10.1039/d3bm00137g
https://doi.org/10.1039/d3bm00137g
Autor:
Anand Kumar Meka, Helen Forgham, Joshua A. McCarroll, Yuxue Cao, Roberta Mazzieri, Amirali Popat, Rosa Mistica C. Ignacio, Friederike M. Mansfeld, Maria Kavallaris, Taskeen Iqbal Janjua, Aria Ahmed-Cox
Publikováno v:
Nanoscale. 13(40)
The blood brain barrier (BBB) and blood tumour barrier (BTB) remain a major roadblock for delivering therapies to treat brain cancer. Amongst brain cancers, glioblastoma (GBM) is notoriously difficult to treat due to the challenge of delivering chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd99ebb23540a358e191a4ecbdb2bb6
https://pubmed.ncbi.nlm.nih.gov/34533167
https://pubmed.ncbi.nlm.nih.gov/34533167
Autor:
Zanib Chaudhary, Nidhi Bansal, Jared A. Miles, Vanessa Jane Banun, Yuao Wu, Amirali Popat, Prarthana V. Rewatkar, Anuja Patil, Tushar Kumeria, Zhi Qu, Hang T. Ta, Taskeen Iqbal Janjua, Benjamin P. Ross
Publikováno v:
ACS Biomaterials Science & Engineering.
Coenzyme-Q10 (CoQ10) is a hydrophobic benzoquinone with antioxidant and anti-inflammatory properties. It is known to reduce oxidative stress in various health conditions. However, due to the low solubility, permeability, stability, and poor oral bioa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f8d2b2893c39472ec2fc6857007ebf7
https://doi.org/10.1021/acsbiomaterials.0c01354
https://doi.org/10.1021/acsbiomaterials.0c01354
Autor:
David S. Ziegler, Maria Kavallaris, Tushar Kumeria, Roberta Mazzieri, Amirali Popat, Friederike M. Mansfeld, Aria Ahmed-Cox, Iqira Saeed, Prarthana V. Rewatkar, Ritu Kulshreshtha, Taskeen Iqbal Janjua
Publikováno v:
Advanced drug delivery reviews. 171
Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive research over the last several decades, the survival rates for GBM have not improved and prognosis remains poor. To date, only a few therapies are approved for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b704ac2515f87abce9a159f6a8168a22
https://pubmed.ncbi.nlm.nih.gov/33486006
https://pubmed.ncbi.nlm.nih.gov/33486006